[Form 4] Mesa Laboratories Inc Insider Trading Activity
Shiraz Ladiwala, a director of Mesa Laboratories, received restricted stock unit vestings and holds common stock. On August 15, 2025, 1,949 RSUs vested and were reported as acquired resulting in 1,949 shares delivered at $0 per share. Additionally, 3,810 RSUs granted on the same date were reported as unvested and remain scheduled to vest on August 15, 2026, representing an additional 3,810 shares. After the vested delivery, the reporting person beneficially owned 5,023 shares of Mesa Laboratories common stock. The Form 4 was filed by one reporting person and lists the reporting person as a director. The filing was signed under power of attorney on August 15, 2025.
Shiraz Ladiwala, membro del consiglio di amministrazione di Mesa Laboratories, ha maturato unit脿 azionarie soggette a restrizioni e detiene azioni ordinarie. Il 15 agosto 2025 sono 1.949 RSU maturate e segnalate come acquisite, corrispondenti alla consegna di 1.949 azioni a $0 per azione. Inoltre, 3.810 RSU concesse in quella stessa data risultano non ancora maturate e sono previste maturare il 15 agosto 2026, rappresentando ulteriori 3.810 azioni. Dopo la consegna delle RSU maturate, la persona segnalante possedeva beneficiariamente 5.023 azioni ordinarie di Mesa Laboratories. Il Modulo 4 猫 stato presentato da un unico dichiarante che figura come direttore. La dichiarazione 猫 stata firmata con procura il 15 agosto 2025.
Shiraz Ladiwala, director de Mesa Laboratories, recibi贸 adjudicaciones de unidades de acciones restringidas y posee acciones ordinarias. El 15 de agosto de 2025 1.949 RSU vencieron y se informaron como adquiridas, entreg谩ndose 1.949 acciones a $0 por acci贸n. Adem谩s, 3.810 RSU concedidas en la misma fecha permanecen no devengadas y est谩n programadas para devengar el 15 de agosto de 2026, representando 3.810 acciones adicionales. Tras la entrega de las RSU devengadas, la persona informante pose铆a beneficiariamente 5.023 acciones ordinarias de Mesa Laboratories. El Formulario 4 fue presentado por una sola persona informante que figura como director. La presentaci贸n fue firmada por poder el 15 de agosto de 2025.
Shiraz Ladiwala電� Mesa Laboratories鞚� 鞚挫偓搿滌劀 鞝滍暅攵� 欤检嫕雼渼(RSU) 旆摑攵勳潉 靾橂牴頄堨溂氅� 氤错喌欤茧ゼ 氤挫湢頃橁碃 鞛堨姷雼堧嫟. 2025雲� 8鞗� 15鞚检棎 1,949 RSU臧� 氩犾姢韺�(甓岆Μ頇曥爼)霅橃柎 旆摑霅� 瓴冹溂搿� 氤搓碃霅橃棃鞙茧┌, 欤茧嫻 $0搿� 1,949欤缄皜 鞝勲嫭霅橃棃鞀惦媹雼�. 霕愴暅 霃欖澕頃� 雮犾鞐� 攵�鞐悳 3,810 RSU電� 鞎勳 氩犾姢韺呺悩歆� 鞎婌晿鞙茧┌ 2026雲� 8鞗� 15鞚检棎 氩犾姢韺呺悹 鞓堨爼鞙茧 於旉皜 3,810欤检棎 頃措嫻頃╇媹雼�. 氩犾姢韺呺悳 欤检嫕鞚� 鞝勲嫭霅� 頉� 氤搓碃鞛愲姅 Mesa Laboratories 氤错喌欤茧ゼ 5,023欤�鞚� 鞁れ鞝� 靻岇湢鞛愲 氤挫湢頃橁碃 鞛堨棃鞀惦媹雼�. Form 4電� 頃� 氇呾潣 氤搓碃鞛愱皜 鞝滌稖頄堨溂氅� 頃措嫻 氤搓碃鞛愲姅 鞚挫偓搿� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 頃措嫻 靹滊電� 2025雲� 8鞗� 15鞚� 鞙勳瀯鞛レ溂搿� 靹滊獏霅橃棃鞀惦媹雼�.
Shiraz Ladiwala, administrateur de Mesa Laboratories, a per莽u des unit茅s d'actions restreintes (RSU) et d茅tient des actions ordinaires. Le 15 ao没t 2025, 1 949 RSU ont acquis des droits et ont 茅t茅 signal茅es comme acquises, entra卯nant la remise de 1 949 actions 脿 0 $ par action. De plus, 3 810 RSU attribu茅es 脿 la m锚me date restent non acquises et sont pr茅vues pour acqu茅rir le 15 ao没t 2026, repr茅sentant 3 810 actions suppl茅mentaires. Apr猫s la livraison des RSU acquises, la personne d茅clarante d茅tenait 脿 titre b茅n茅ficiaire 5 023 actions ordinaires de Mesa Laboratories. Le formulaire 4 a 茅t茅 d茅pos茅 par une seule personne d茅clarante, qui est indiqu茅e en tant qu'administrateur. Le d茅p么t a 茅t茅 sign茅 par procuration le 15 ao没t 2025.
Shiraz Ladiwala, ein Direktor von Mesa Laboratories, erhielt Restricted Stock Units (RSUs) und h盲lt Stammaktien. Am 15. August 2025 wurden 1.949 RSUs f盲llig und als erworben gemeldet; dabei wurden 1.949 Aktien zu $0 pro Aktie geliefert. Zus盲tzlich sind 3.810 RSUs, die am selben Datum gew盲hrt wurden, noch nicht vestiert und sollen am 15. August 2026 vesten, was weitere 3.810 Aktien darstellt. Nach der Lieferung der vested RSUs besa脽 die meldende Person wirtschaftlich 5.023 Aktien von Mesa Laboratories. Das Formular 4 wurde von einer meldenden Person eingereicht, die als Direktor aufgef眉hrt ist. Die Einreichung wurde am 15. August 2025 per Vollmacht unterzeichnet.
- None.
- None.
Insights
TL;DR: Routine insider vesting resulted in 1,949 shares delivered and 3,810 RSUs remaining unvested; no sale or external transaction noted.
The filing documents standard equity compensation activity: 1,949 restricted stock units vested and were converted into shares at no cost to the director, raising beneficial ownership to 5,023 shares. A separate grant of 3,810 RSUs remains subject to future vesting on 08/15/2026. There is no cash transaction, sale, or transfer that would signal immediate liquidity or diversification by the insider. From an investor-impact perspective, this is a routine disclosure of compensation-related share issuance rather than a market-moving event.
TL;DR: This Form 4 reports scheduled equity compensation vesting for a director; it aligns with typical executive/board award schedules.
The report indicates compliance with Section 16 reporting: vested RSUs converted to 1,949 shares and an additional 3,810 RSUs remain outstanding with a one-year vesting horizon. The director is identified and the form was executed via power of attorney. There are no indications of unusual timing, accelerated vesting, or related-party transactions disclosed here. Governance implications are limited as this reflects standard equity compensation administration.
Shiraz Ladiwala, membro del consiglio di amministrazione di Mesa Laboratories, ha maturato unit脿 azionarie soggette a restrizioni e detiene azioni ordinarie. Il 15 agosto 2025 sono 1.949 RSU maturate e segnalate come acquisite, corrispondenti alla consegna di 1.949 azioni a $0 per azione. Inoltre, 3.810 RSU concesse in quella stessa data risultano non ancora maturate e sono previste maturare il 15 agosto 2026, rappresentando ulteriori 3.810 azioni. Dopo la consegna delle RSU maturate, la persona segnalante possedeva beneficiariamente 5.023 azioni ordinarie di Mesa Laboratories. Il Modulo 4 猫 stato presentato da un unico dichiarante che figura come direttore. La dichiarazione 猫 stata firmata con procura il 15 agosto 2025.
Shiraz Ladiwala, director de Mesa Laboratories, recibi贸 adjudicaciones de unidades de acciones restringidas y posee acciones ordinarias. El 15 de agosto de 2025 1.949 RSU vencieron y se informaron como adquiridas, entreg谩ndose 1.949 acciones a $0 por acci贸n. Adem谩s, 3.810 RSU concedidas en la misma fecha permanecen no devengadas y est谩n programadas para devengar el 15 de agosto de 2026, representando 3.810 acciones adicionales. Tras la entrega de las RSU devengadas, la persona informante pose铆a beneficiariamente 5.023 acciones ordinarias de Mesa Laboratories. El Formulario 4 fue presentado por una sola persona informante que figura como director. La presentaci贸n fue firmada por poder el 15 de agosto de 2025.
Shiraz Ladiwala電� Mesa Laboratories鞚� 鞚挫偓搿滌劀 鞝滍暅攵� 欤检嫕雼渼(RSU) 旆摑攵勳潉 靾橂牴頄堨溂氅� 氤错喌欤茧ゼ 氤挫湢頃橁碃 鞛堨姷雼堧嫟. 2025雲� 8鞗� 15鞚检棎 1,949 RSU臧� 氩犾姢韺�(甓岆Μ頇曥爼)霅橃柎 旆摑霅� 瓴冹溂搿� 氤搓碃霅橃棃鞙茧┌, 欤茧嫻 $0搿� 1,949欤缄皜 鞝勲嫭霅橃棃鞀惦媹雼�. 霕愴暅 霃欖澕頃� 雮犾鞐� 攵�鞐悳 3,810 RSU電� 鞎勳 氩犾姢韺呺悩歆� 鞎婌晿鞙茧┌ 2026雲� 8鞗� 15鞚检棎 氩犾姢韺呺悹 鞓堨爼鞙茧 於旉皜 3,810欤检棎 頃措嫻頃╇媹雼�. 氩犾姢韺呺悳 欤检嫕鞚� 鞝勲嫭霅� 頉� 氤搓碃鞛愲姅 Mesa Laboratories 氤错喌欤茧ゼ 5,023欤�鞚� 鞁れ鞝� 靻岇湢鞛愲 氤挫湢頃橁碃 鞛堨棃鞀惦媹雼�. Form 4電� 頃� 氇呾潣 氤搓碃鞛愱皜 鞝滌稖頄堨溂氅� 頃措嫻 氤搓碃鞛愲姅 鞚挫偓搿� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 頃措嫻 靹滊電� 2025雲� 8鞗� 15鞚� 鞙勳瀯鞛レ溂搿� 靹滊獏霅橃棃鞀惦媹雼�.
Shiraz Ladiwala, administrateur de Mesa Laboratories, a per莽u des unit茅s d'actions restreintes (RSU) et d茅tient des actions ordinaires. Le 15 ao没t 2025, 1 949 RSU ont acquis des droits et ont 茅t茅 signal茅es comme acquises, entra卯nant la remise de 1 949 actions 脿 0 $ par action. De plus, 3 810 RSU attribu茅es 脿 la m锚me date restent non acquises et sont pr茅vues pour acqu茅rir le 15 ao没t 2026, repr茅sentant 3 810 actions suppl茅mentaires. Apr猫s la livraison des RSU acquises, la personne d茅clarante d茅tenait 脿 titre b茅n茅ficiaire 5 023 actions ordinaires de Mesa Laboratories. Le formulaire 4 a 茅t茅 d茅pos茅 par une seule personne d茅clarante, qui est indiqu茅e en tant qu'administrateur. Le d茅p么t a 茅t茅 sign茅 par procuration le 15 ao没t 2025.
Shiraz Ladiwala, ein Direktor von Mesa Laboratories, erhielt Restricted Stock Units (RSUs) und h盲lt Stammaktien. Am 15. August 2025 wurden 1.949 RSUs f盲llig und als erworben gemeldet; dabei wurden 1.949 Aktien zu $0 pro Aktie geliefert. Zus盲tzlich sind 3.810 RSUs, die am selben Datum gew盲hrt wurden, noch nicht vestiert und sollen am 15. August 2026 vesten, was weitere 3.810 Aktien darstellt. Nach der Lieferung der vested RSUs besa脽 die meldende Person wirtschaftlich 5.023 Aktien von Mesa Laboratories. Das Formular 4 wurde von einer meldenden Person eingereicht, die als Direktor aufgef眉hrt ist. Die Einreichung wurde am 15. August 2025 per Vollmacht unterzeichnet.
FAQ
What insider activity did the Form 4 report for Mesa Laboratories (MLAB)?
How many Mesa Laboratories shares does the reporting person beneficially own after the transaction?
Was there a sale or purchase involving cash in this Form 4 filing for MLAB?
When are the unvested RSUs scheduled to vest according to the filing?
Who signed the Form 4 for the reporting person?
